Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21755878 | 0.76 | — | — | |
| SCHEMBL6832062 | 0.73 | — | — | |
| SCHEMBL8927825 | 0.72 | TSHR (0.30) | TSHRTDP1 | |
| SCHEMBL10486704 | 0.72 | TSHR (0.30) | TSHRTDP1 | |
| SCHEMBL10794688 | 0.71 | TSHR (0.46) | TSHRTDP1 | |
| SCHEMBL13458323 | 0.69 | TSHR (0.38) | TSHRTDP1 | |
| SCHEMBL1637976 | 0.67 | TSHR (0.35) | TSHRTDP1 | |
| SCHEMBL1971304 | 0.67 | TSHR (0.35) | TSHRTDP1 | |
| SCHEMBL16808778 | 0.67 | PDE2A (0.30) | — | |
| SCHEMBL13512602 | 0.67 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170362254-A1 | MELAMPOMAGNOLIDE B DIMERS | BIOVENTURES, LLC | 2017-12-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170362254-A1 | MELAMPOMAGNOLIDE B DIMERS | SUCLG2, MYADM, SUCLA2 | TSHR 4139/4885TDP1 4730/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.